MAM
InMobi appoints Shrikant Latkar as global marketing VP
MUMBAI: Bengaluru-based mobile advertising network InMobihas has appointed Shrikant Latkar as vice president, global marketing.
Latkar comes in from innovation and technology services company Aricent Group where he was responsible for marketing all products and solutions for the product engineering services, carrier services and solutions units.
Latkar will be based at the InMobi San Francisco office in the USA. He will be responsible for leading the various marketing related aspects for InMobi which includes aligning the marketing strategy and brand positioning.
Latkar brings to the table over 18 years of experience in the technology industry and has held leadership roles in marketing, product management and engineering at firms like Juniper Networks, Avaya and Lucent Technologies.
Latkar said, “InMobi has enjoyed rapid growth and has helped to shape the success of the mobile advertising industry as it stands today. Its ability to offer enormous global reach, combined with a unique rich media platform – Sprout, for building and delivering HTML5 rich media ads to mobile devices gives it a significant advantage over the competition. I look forward to leading InMobi‘s marketing during such an exciting time in the industry.”
InMobi founder and CEO Naveen Tewari said, “Shrikant joins InMobi as we continue to expand globally and offer the latest innovation to customers. We are very focused on creating global synergies across our products and solutions, and Shrikant‘s appointment is central in helping us to achieve this. With his vast experience in successfully bringing products to market and effectively communicating them, Shrikant is the ideal person to help us achieve our goals and create a cohesive offering on a global scale.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
